Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Common-Size Balance Sheet: Assets 
Quarterly Data

Cytokinetics Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Cash and cash equivalents 13.46 8.80 11.42 6.46 9.87 12.13 13.48 13.39 10.94 6.58 7.73 15.55 42.36 26.29 19.40 12.57 21.15 17.33 19.84 20.01 12.00 18.99 41.09
Short-term investments 59.35 63.74 63.20 70.66 70.77 63.81 57.64 42.67 46.77 55.49 66.02 71.39 44.18 65.35 66.62 65.10 67.45 69.88 69.09 74.10 79.33 74.82 48.74
Accounts receivable 0.34 0.13 0.11 0.01 0.21 0.26 0.71 6.16 0.08 0.48 0.78 0.83 1.05 0.97 1.05 1.78 3.51 4.54 2.10 1.06 3.98 0.10 0.01
Contract assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.29 1.24 2.16 2.55 4.20 6.63
Prepaid expenses and other current assets 2.66 2.55 1.76 1.23 1.33 1.85 0.99 1.45 2.01 1.99 0.52 1.08 0.67 1.56 0.99 1.20 2.09 1.27 1.58 1.02 0.84 0.68 0.82
Current assets 75.80% 75.21% 76.49% 78.36% 82.18% 78.04% 72.82% 63.67% 59.81% 64.55% 75.06% 88.84% 88.25% 94.18% 88.06% 80.66% 94.21% 93.31% 93.85% 98.34% 98.69% 98.78% 97.29%
Long-term investments 2.09 3.45 4.54 4.60 2.65 1.38 9.00 18.07 23.12 13.06 6.01 6.92 8.64 0.00 6.43 14.72 0.00 1.14 0.00 0.00 0.00 0.00 1.43
Property and equipment, net 10.21 9.90 8.86 7.93 7.46 10.18 8.85 8.71 6.51 6.55 4.02 2.50 1.62 2.41 2.01 1.56 1.93 1.49 1.60 1.52 1.17 1.05 1.13
Operating lease right-of-use assets 10.79 10.37 9.19 8.15 6.98 9.35 8.48 8.69 9.75 14.71 13.81 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other assets 1.11 1.07 0.91 0.95 0.72 1.04 0.85 0.85 0.81 1.14 1.11 1.19 1.49 3.41 3.50 3.06 3.87 4.07 4.55 0.14 0.14 0.17 0.15
Non-current assets 24.20% 24.79% 23.51% 21.64% 17.82% 21.96% 27.18% 36.33% 40.19% 35.45% 24.94% 11.16% 11.75% 5.82% 11.94% 19.34% 5.79% 6.69% 6.15% 1.66% 1.31% 1.22% 2.71%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Cytokinetics Inc. current assets as a percentage of total assets decreased from Q1 2023 to Q2 2023 but then slightly increased from Q2 2023 to Q3 2023.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Cytokinetics Inc. property and equipment, net as a percentage of total assets increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Cytokinetics Inc. non-current assets as a percentage of total assets increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023.